Éloi Gagnon

15PUBLICATIONS
103CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Cardiology (incl. cardiovascular diseases)Molecular targetsMetabolic medicineEarly childhood education
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Feb 04, 2026
Integrative genetic and liver transcriptomic analyses identify TRIB1AL as a target for steatotic liver disease.

Émilie Gobeil, Jérôme Bourgault, Eloi Gagnon

|Jul 01, 2025
Appraisal of multiple polygenic risk scores to estimate the risk of myocardial infarction and coronary artery lesions.

Hasanga D Manikpurage, Jérôme Bourgault, Ursula Houessou

|May 10, 2025
RNA interference versus antibody-based PCSK9 inhibition for the prevention of cardiovascular disease: a drug-target Mendelian randomization study.

Eloi Gagnon, Dipender Gill, Jérôme Bourgault

|Mar 31, 2025
Remnant cholesterol concentrations best explain the cardiovascular benefit of APOC3 genetic inhibition: a drug target Mendelian randomization study.

Eloi Gagnon, Dipender Gill, Stephen Burgess

|Mar 07, 2025
Evaluating the Cardiometabolic Efficacy and Safety of Lipoprotein Lipase Pathway Targets in Combination With Approved Lipid-Lowering Targets: A Drug Target Mendelian Randomization Study.

Eloi Gagnon, Dipender Gill, Dominique Chabot

|Jun 27, 2024
Genetic assessment of efficacy and safety profiles of coagulation cascade proteins identifies Factors II and XI as actionable anticoagulant targets.

Eloi Gagnon, Arnaud Girard, Jérôme Bourgault

Pageof 3

Frequent Collaborators

9 joint publications

Benoit J Arsenault

7 joint publications

Sébastien Thériault

6 joint publications

Jérôme Bourgault

5 joint publications

Patricia L Mitchell